Veracyte Ownership | Who Owns Veracyte?


OverviewForecastRevenueFinancialsChartTranscripts

Veracyte Ownership Summary


Veracyte is owned by 109.23% institutional investors, 0.53% insiders. Vanguard group is the largest institutional shareholder, holding 10.66% of VCYT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.96% of its assets in Veracyte shares.

VCYT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVeracyte109.23%0.53%-9.76%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group8.21M10.66%$325.18M
Blackrock7.79M10.42%$168.88M
Blackrock funding, inc. /de7.73M9.88%$208.90M
Artisan partners limited partnership6.32M8.08%$170.88M
Wellington management group llp4.08M5.30%$161.75M
Ark investment management3.80M4.86%$102.72M
State street2.91M3.89%$63.03M
Dimensional fund advisors lp2.88M3.74%$114.16M
Arrowmark colorado2.58M3.30%$69.71M
Sumitomo mitsui trust2.49M3.24%$98.74M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Silverarc capital management448.50K2.24%$12.12M
Perkins capital management81.95K2.23%$2.22M
Palisades investment partners162.41K1.92%$4.39M
Soleus capital management715.44K1.28%$19.34M
Arrowmark colorado2.58M1.26%$69.71M
Efg asset management (north america)206.23K1.11%$8.16M
Cannon global investment management15.50K0.86%$418.96K
Oberweis asset management inc/726.49K0.85%$19.64M
Granite investment partners636.22K0.84%$17.20M
Ark investment management3.80M0.75%$102.72M

Top Buyers

HolderShares% AssetsChange
Fmr2.08M0.00%2.02M
Artisan partners limited partnership6.32M0.25%1.08M
Soleus capital management715.44K1.28%715.44K
Deerfield management company, l.p. (series c)625.00K0.31%625.00K
Blackrock7.79M0.00%581.69K

Top Sellers

HolderShares% AssetsChange
State street2.91M0.00%-1.42M
Driehaus capital management---1.35M
William blair investment management---811.79K
Champlain investment partners---800.36K
Jennison associates265.87K0.00%-734.49K

New Positions

HolderShares% AssetsChangeValue
Soleus capital management715.44K1.28%715.44K$19.34M
Deerfield management company, l.p. (series c)625.00K0.31%625.00K$16.89M
Norges bank225.60K0.00%225.60K$8.93M
Abrdn181.92K0.01%181.92K$4.92M
Balyasny asset management170.25K0.01%170.25K$4.60M

Sold Out

HolderChange
Newedge advisors-2.00
Global financial private client-5.00
Kohmann bosshard financial services-6.00
True wealth design-6.00
Quadrant capital group-9.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025273-5.21%85,426,3961.00%1090.93%1381.47%98-8.41%
Mar 31, 20259-97.20%3,530,599-95.70%40.04%5-96.84%3-97.41%
Dec 31, 20243012.73%77,106,580-5.52%1000.89%145-9.94%10922.47%
Sep 30, 202429222.18%81,612,672-0.60%1050.88%16238.46%887.32%
Jun 30, 2024239-2.05%82,106,4620.48%1090.92%117-21.48%8224.24%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF4.68M5.96%716.00
ARK Innovation ETF3.23M4.11%307.14K
Vanguard US Total Market Shares ETF2.46M3.16%2.69K
Vanguard Total Stock Mkt Idx Inv2.44M3.11%-51.87K
ARK Disruptive Innovation Full Composite2.36M3.00%-119.19K
Vanguard Explorer Inv2.28M2.91%-385.96K
Fidelity Select Medical Tech and Devcs2.23M2.85%-
Vanguard Small Cap Index1.90M2.42%-13.32K
iShares Russell 2000 ETF1.84M2.35%-35.07K
Fidelity Select Health Care1.52M1.94%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 13, 2025EASTHAM KARIN-Sell$122.39K
Jun 13, 2025Bhanji Muna-Sell$122.37K
Jun 04, 2025Leite John Chief Commercial Officer-CLIASell$76.41K
Mar 07, 2025Leite John Chief Commercial Officer-CLIASell$74.48K
Mar 07, 2025Leite John Chief Commercial Officer-CLIASell$160.15K

Insider Transactions Trends


DateBuySell
2025 Q2-1
2025 Q1-12
2024 Q4-13
2024 Q3-21
2024 Q2-5

VCYT Ownership FAQ


Who Owns Veracyte?

Veracyte shareholders are primarily institutional investors at 109.23%, followed by 0.53% insiders and -9.76% retail investors. The average institutional ownership in Veracyte's industry, Biotech Stocks , is 304.14%, which Veracyte falls below.

Who owns the most shares of Veracyte?

Veracyte’s largest shareholders are Vanguard group (8.21M shares, 10.66%), Blackrock (7.79M shares, 10.42%), and Blackrock funding, inc. /de (7.73M shares, 9.88%). Together, they hold 30.97% of Veracyte’s total shares outstanding.

Does Blackrock own Veracyte?

Yes, BlackRock owns 10.42% of Veracyte, totaling 7.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 168.88M$. In the last quarter, BlackRock increased its holdings by 581.69K shares, a 8.07% change.

Who is Veracyte’s biggest shareholder by percentage of total assets invested?

Silverarc capital management is Veracyte’s biggest shareholder by percentage of total assets invested, with 2.24% of its assets in 448.5K Veracyte shares, valued at 12.12M$.

Who is the top mutual fund holder of Veracyte shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Veracyte shares, with 5.96% of its total shares outstanding invested in 4.68M Veracyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools